We have launched a Nanoparticle Analysis Service that leverages the extreme sensitivity of our Delaware Flow Nanocytometer® and offers researchers a simple way to access the power of multi-parametric flow cytometry based analysis of their sample.

In August, we were very pleased to receive yet another research grant from the National Institutes of Health. This project takes advantage of the unique 6-nm resolution and multicolor capabilities of our Delaware Flow NanoCytometer® to analyze exosomes and their anti-aging properties.

We are thrilled to be collaborating with renowned extracellular vesicle researcher Dr. Fatah Kashanchi at George Mason University. As always, many thanks to the NIH, the reviewers, and the NIGMS staff for supporting our work.

The Fourth Annual Meeting of the American Society for Intercellular Communication was held this October 17th to 19th in Bethesda, Maryland, and focused on the technological and diagnostic advancements in the field of extracellular vesicles and other nanoparticles.

The Delaware was exhibited at our booth, and Dr. Vacca presented a talk entitled Multicolor, High-Resolution, Clog-Free Exosome Analysis with the Delaware Flow NanoCytometer®.

Thank you to the organizers at ASIC and everyone who stopped by our booth to check out the Delaware in person!

“This is the Holy Grail. This is what everyone has been waiting for.” 
– Conference attendee commenting on the Delaware

In October, Dr. Vacca presented a webinar about the challenges and opportunities in the analysis of nanoparticles. The talk, entitled “Extremely Small & Incredibly Dim: The Quest to Catch the Nanoparticles Responsible for Everything”, was hosted by the Professional and Technical Consultants Association – PATCA.

Dr. Vacca described various technologies used to detect the super small, and illustrated how the Delaware uses innovative optics, fluidics, and algorithms to overcome the daunting physical challenges inherent in detecting particles smaller than 250 nm.

We thank Sean Murphy, Theresa Shafer, and the rest of the PATCA team for hosting this event. Watch the webinar (link below) for an approachable introduction to the intricacies of nanoparticle analysis.

Tech4EVIta this September was a success! Hosted by the Italian Society of Extracellular Vesicles in Trieste, Italy, the workshop focused on advanced technologies that separate and characterize EVs.

We were honored to be a sponsor at the event, and Dr. Vacca joined the workshop virtually as a speaker and presented a talk on our Delaware Flow NanoCytometer and its capabilities for nanoparticle analysis.

Thank you to Andrea Zanella, our Senior Account Manager for Europe, and Camilla lafrate, our partner from CytoFlowService, for staffing our table at the event.

A warm thank you to the International Society for the Advancement of Cytometry for another wonderful CYTO!

Held in Edinburgh, Scotland, the conference was another great success for Kinetic River. In partnership with CytoFlowService, our booth was staffed by our Senior Account Manager for Europe, Andrea Zanella, and our European service and support partners, Gianni Contini and Marco Contini. Thank you, team, for your hard work!

We showcased the Delaware‘s new look, and were visited by a number of interested colleagues and good friends, including Andrea Cossarizza, Peter Lopez, and János Szöllõsi. Thank you to everyone who stopped by.

We are greatly looking forward to next year’s CYTO conference, to be held in Denver, Colorado, from May 31st to June 4th. Save the date!

In April, we attended SelectBIO’s meeting on Extracellular Vesicles (EVs) and Nanoparticles 2024: Diagnostics, Delivery, Therapeutics, and unveiled the new look of our Delaware Flow Nanocytometer!

Kinetic River was a sponsor and exhibitor of the event, and Dr. Giacomo Vacca presented a talk entitled “Multicolor, High-Resolution Exosome Analysis with the Delaware Flow NanoCytometer®”, in which he highlighted the unprecedented 6 nm resolution obtained on the Delaware. (See graph in NIH Grant section above)

Dr. Vacca took some lovely photos while sightseeing around Miami, which you can view on our website.

Dr. Christopher Ward, Associate Professor at the University of Kansas Medical Center (see Nanoparticle Analysis Service section above), and Dr. Vacca co-presented a webinar, hosted by SelectBIO: “Flow Cytometry for Studying Exosomes and Extracellular Vesicles.”

Dr. Ward is a leading expert on polycystic kidney disease (PKD), and he’s been collaborating with Kinetic River to develop better diagnostic assays based on his biomarker expertise and our instrument technology.

Learn more about our joint efforts by watching the webinar or downloading the slides (links below).

We are very pleased that our trademark applications for our tagline, Where Light Meets Life, and for our Freedom Flow platform, have been accepted and issued by the USPTO.

Freedom Flow is our family of time-resolved flow cytometers under development—ones that offer freedom from compensation, freedom from autofluorescence, and freedom from labeling.

Kinetic River’s tagline highlights that crucial intersection in flow cytometry between light and life, where all the magic happens! Flow cytometers work by shining laser light on fast-moving particles (cells or nanoparticles) in a flowing stream. We couldn’t think of a more apt tagline for these kinds of instruments!

In August, HansaBioMed Life Sciences Ltd featured the Delaware in their brochure on the use of their Fluo-EVs on advanced particle analyzers.

We value the collaboration with HansaBioMed, and look forward to further joint efforts. Many thanks to Paolo Guazzi for showing off our instrument’s capabilities for multiparameter analysis using these extremely versatile nanoparticle standards.

Kinetic River was recently issued U.S. Patents 11,965,812, “Apparatus and Methods for Particle Analysis and Autofluorescence Discrimination,” and 11,965,815, “Flow Cytometry Apparatus and Method.”

These patents further strengthen our intellectual property in flow cytometry as well as imaging. Kinetic River has been issued 26 patents (22 U.S. patents, and one each in the E.U., China, Japan, and Canada); these latest additions total 81 patents for our President and Founder, Dr. Giacomo Vacca.

We are very happy to have Andrea Zanella on our team as our new Senior Account Manager for Europe. Andrea brings to KRC decades of commercial experience in diagnostics and research instrumentation and reagents, including 9 years at BD Biosciences. Andrea has already hit the ground running, spreading the word about the Delaware across the continent. Make sure to say hi at the next conference!